Loading...

GRFL

GRFS

GRIFOLS SA

(GRFS)

2024 6-K

IPO Evaluation Announcement

24 Mar '26

Grifols Financial Report

26 Feb '26

Financial Report 2025

26 Feb '26

Management Changes

8 Jan '26

EMA Certification Achieved

16 Dec '25

Q3 2025 Results

4 Nov '25

Board Committee Created

29 Sep '25

Strong Revenue Growth

30 Jul '25

Dividend Announcement

29 Jul '25

Board Committee Update

29 Jul '25

Delisting Offer Update

11 Jun '25

Shareholders Meeting Outcome

5 Jun '25

Q1 2025 Results

12 May '25

Biotest Acquisition

6 May '25

Shareholders Meeting Notice

2 May '25

Potential Offer Update

2 Apr '25

Delisting Purchase Offer

31 Mar '25

Fraud Allegations Response

10 Mar '25

Capital Markets Day

27 Feb '25

Financial Results Report

26 Feb '25

Strong Q4 Results

26 Feb '25

Board Changes

25 Feb '25

Debt Refinancing Update

23 Dec '24

Debt Management Update

11 Dec '24

Board Appointments

9 Dec '24

Transaction Status Update

27 Nov '24

Rejection of Offer

19 Nov '24

Valuation Disagreement

19 Nov '24

Q3 2024 Results

7 Nov '24

Disciplinary Proceeding

25 Sep '24

Management Changes

23 Sep '24

Performance Report

30 Jul '24

Financial Restatement

30 Jul '24

Board Meeting Update

19 Jul '24

Board Appointments

16 Jul '24

Board Meeting Update

12 Jul '24

Possible Acquisition News

8 Jul '24

New CFO Appointment

5 Jul '24

Equity Stake Sale

3 Jul '24

Filing Report

27 Jun '24

6-K Filing Summary

18 Jun '24

Filing Summary

14 Jun '24

Bond Issuance

4 Jun '24

Management Changes

31 May '24

Q1 2024 Financials

14 May '24

Shareholders Meeting Call

10 May '24

Corporate Governance Update

7 May '24

Equity Stake Sale

6 May '24

Bond Placement Success

30 Apr '24

Debt Offering Announcement

23 Apr '24

Board Changes

18 Apr '24

Financial Updates

10 Apr '24

Clarification on Liabilities

5 Apr '24

Financial Reporting Update

4 Apr '24

Management Change

2 Apr '24

Gotham Report Update

21 Mar '24

Credit Rating Update

14 Mar '24

Financial Report 2023

8 Mar '24

Annual Accounts Report

8 Mar '24

Media Clarification

1 Mar '24

Cash Flow Update

1 Mar '24

Strategic Alliance Update

1 Mar '24

2023 Financial Highlights

29 Feb '24

Management Change

27 Feb '24

Grifols Refutes Accusations

20 Feb '24

Management Change

6 Feb '24

Management Changes

5 Feb '24

Lawsuit Filed

26 Jan '24

Sale Update

16 Jan '24

Conference Call Notice

10 Jan '24

Management Support Announce...

10 Jan '24

False Claims Response

9 Jan '24

False Allegations Denied

9 Jan '24

External Links:

SEC

Grifols SA confirmed that the sale of 20% of Shanghai RAAS Blood Products is proceeding as planned, with expectations to close the deal in the first half of FY 2024, despite recent market concerns expressed on January 14, 2024.

AI Assistant

GRIFOLS SA

2024

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.